Selectively high efficacy of eribulin against high-grade invasive recurrent and/or metastatic squamous cell carcinoma of the head and neck

Patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) have a poor prognosis. Over the past decade, a major development in the first-line treatment of R/M SCCHN was the introduction of cetuximab in combination with platinum plus 5-fluorouracil chemotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Kobayashi, Yutaka, Kitahara, Hiroko, Hirai, Mariko, Tanaka, Akira, Jokaji, Rei, Kobayashi, Kazuhiko, Bou-Gharios, George, Nakamura, Hiroyuki, Kawashiri, Shuichi
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507455/
https://ncbi.nlm.nih.gov/pubmed/31186718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados